Log In
Print this Print this

Temodex, temozolomide

  Manage Alerts
Collapse Summary General Information
Company Belarusian State University
DescriptionLocally acting formulation of the alkylating chemotherapeutic temozolomide
Molecular Target DNA
Mechanism of ActionAlkylating agent
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationBrain cancer
Indication DetailsTreat glioblastoma multiforme and astrocytoma
Regulatory Designation
PartnerDouble Bond Pharmaceutical International AB

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today